Evidence map›Paper›PMID 28405497›Full record

ArticleOncoimmunology

Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.

Silvia C Formenti, Encouse B Golden, Judith D Goldberg, Xiaochun Li, Jessica Taff, Maria B Fenton-Kerimian, Sharanya Chandrasekhar, Sandra Demaria, Yelena Novik

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Silvia C FormentiDepartment of Radiation Oncology, Weill Cornell Medicine , New York, NY, USA.
Encouse B GoldenDepartment of Radiation Oncology, Weill Cornell Medicine , New York, NY, USA.
Judith D GoldbergDepartments of Population Health and Environmental Medicine, New York University School of Medicine , New York, NY, USA.
Xiaochun LiDepartments of Population Health and Environmental Medicine, New York University School of Medicine , New York, NY, USA.
Jessica TaffDepartment of Medicine, New York University School of Medicine , New York, NY, USA.
Maria B Fenton-KerimianDepartment of Radiation Oncology, Weill Cornell Medicine , New York, NY, USA.
Sharanya ChandrasekharDepartment of Radiation Oncology, Weill Cornell Medicine , New York, NY, USA.
Sandra DemariaDepartment of Radiation Oncology, Weill Cornell Medicine , New York, NY, USA.
Yelena NovikDepartment of Medicine, New York University School of Medicine , New York, NY, USA.
Cornell University · USNew York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Nikon A1Rsi resonant spectral confocal microscopeS10OD010580 · OD · STANFORD UNIVERSITY · PI FULLER, MARGARET T · 2013 to 2013
$377k
Sandy Recovery Ventana Medical Systems Discovery XTS10OD018338 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHIRIBOGA, LUIS A · 2014 to 2014
$123k
NCI NIH HHS P30 CA016087NIH HHS S10 OD010580NIH HHS S10 OD018338
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adjuvant treatmentchemo-radiationclinical trialimmunogenic cell deathtriple negative breast cancertumor-infiltrating lymphocytes

Identifiers

PMID28405497
PMCPMC5384379
OpenAlexW2566459523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.